Azurity Pharmaceuticals recalls

Azurity Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 7 Feb 2024. The most frequent reason is packaging defects.

Total recalls4since 2021

Last 12 months0reported

Class I250% of total

Ongoing0latest 7 Feb 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 2 50%Class II 1 25%Class III 1 25%

Why azurity pharmaceuticals is recalled

Product types

Brands

By year

2024250%
2023125%
2021125%

All azurity pharmaceuticals recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
7 Feb 2024Drug	CLASS I	Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg recalledZenzedi	Azurity Pharmaceuticals	Packaging Defects	Nationwide
10 Jan 2024Drug	CLASS III	Eprontia (topiramate) oral solution, 25 mg/mL recalledEprontia	Azurity Pharmaceuticals	Potency & Assay	Nationwide
12 Apr 2023Drug	CLASS II	Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recalledTestosterone Cypionate	Azurity Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
13 Oct 2021Drug	CLASS I	Firvanq (vancomycin hydrochloride for oral solution) recalledFirvanq	Azurity Pharmaceuticals	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.